Proprietary Delivery Technology
Much of standard creatine is lost before your body can use it. CGG Amino-Bridge™ is CREGEN's amino acid delivery approach — pairing creatine with glycine and glutamine to improve absorption, retention and bioavailability for brain and body.
CGG Amino-Bridge™ Performance Data
Creatine monohydrate has been studied for decades, and its role in cellular energy and ATP resynthesis is well established. The challenge isn't whether creatine works — it's how much of each dose your body actually absorbs and holds onto.
A meaningful share of orally ingested creatine is poorly absorbed or excreted before tissues can use it — much of it lost in the urine. That means a lot of every standard dose is wasted, which is why high doses and loading phases became common workarounds.
The goal of a better delivery system is simple: improve absorption and retention so more of each dose reaches and stays in the tissue that needs it — supporting energy in both body and brain.
Where Standard Creatine Is Lost
A three-stage delivery approach designed to improve absorption and retention — so more of each creatine dose is held onto and made available to your tissues.
Creatine monohydrate is paired with Glycine and Glutamine into the CGG Amino-Bridge™ complex. The pairing is designed to support the body's amino-acid transport pathways and improve how much creatine is absorbed and retained.
Pairing creatine with glycine and glutamine is intended to support amino-acid transport pathways and reduce how much creatine is lost before it can be used — keeping more of each dose available to the body.
With more creatine absorbed and retained, more is available for cellular energy and ATP resynthesis — the well-documented role creatine plays in both muscle and the brain — from a single daily dose.
CGG stands for Creatine-Glycine-Glutamine. Each component plays a critical, non-redundant role in the delivery mechanism. This is not a blend — it is a bonded complex where each molecule is structurally essential.
Delivery Pathway vs Standard
Where measured, these point back to an independent EIMEC pilot study — preliminary findings, honestly framed, not marketing claims.
A direct comparison across every metric that matters — from molecular delivery to day-to-day user experience.
| Feature | Standard Creatine Monohydrate | CREGEN CGG Amino-Bridge™ |
|---|---|---|
| Bioavailability | Limited by urinary loss | ✓ Greater (preliminary) |
| Urinary Creatine Loss | ✗ Higher — much excreted | ✓ ~56% lower vs competitor (pilot, p<0.05) |
| Retention & Absorption | ✗ Lower — needs high doses | ✓ Improved by amino-acid pairing |
| Loading Phase Required | ✗ 5–7 days at 20g/day | ✓ None — immediate saturation |
| Daily Dose | 3–5g (maintenance) · 20g (loading) | ✓ 1 sachet per day |
| GI Bloating | ✗ Common — especially loading | ✓ None — zero GI complaints |
| Water Retention | ✗ Visible in loading phase | ✓ No subcutaneous retention |
| Muscle + Brain Delivery | ✗ Muscle only | ✓ Dual-tissue simultaneous |
| Timing Windows | Pre/post workout recommended | ✓ Anytime — no timing required |
| Independent Testing | General literature only | ✓ EIMEC Barcelona — controlled pilot (preliminary) |
| Research Origin | Generic synthesis | ✓ KAIST — South Korea |
One sachet. No loading phase. No bloating. The CGG Amino-Bridge™ approach to creatine for brain and body — built on early research from KAIST and tested in an independent EIMEC pilot.